Submitted by Sean Maden on Fri May 22, 2015.
The biotech industry is booming. Some reservations notwithstanding, influxes of venture capital reflect economic robustness in the biotech market, and the recent pledge of funds for personalized (or "precision") medical research by the Obama administration reflect widespread public interest in the industry.
Amidst this upswing, many are still hesitant to call Seattle a biotech hub. This is for several ... Read more
